Among CD4+ T cells, there was a predominant Th2 and Th17 response with increased gene expression of GATA3 and RORG transcription factors, more prominent in severe COVID-19 and SARS-CoV-2 antibody-producing patients (Fig. 3F). This evidence concerns the gene CD4 and COVID-19.